A detailed history of Baird Financial Group, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 52,182 shares of TGTX stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,182
Holding current value
$1.54 Million
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$17.21 - $25.28 $898,052 - $1.32 Million
52,182 New
52,182 $1.22 Million
Q4 2023

Feb 14, 2024

BUY
$6.68 - $18.81 $263,713 - $742,581
39,478 New
39,478 $674,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.